...
机译:直肠癌中Mcl-1表达的变化与新辅助放疗的关系
Division of Oncology Department of Internal Medicine I Vienna University Medical School;
Department of Otorhinolaryngology Vienna University Medical School;
Department of Pathology Vienna University Medical School;
Department of Surgery Vienna University Medical School;
Department of Otorhinolaryngology Vienna University Medical School;
Department of Radiotherapy Vienna University Medical School;
Division of Oncology Department of Internal Medicine I Vienna University Medical SchoolCenter of Excellence in Clinical and Experimental Oncology;
Department of Otorhinolaryngology Vienna University Medical School;
Mcl-1; Apoptosis; Rectal adenocarcinoma; Irradiation;
机译:基于直肠癌的5-FU新辅助放化疗后胸苷酸合酶,胸苷磷酸化酶,二氢嘧啶脱氢酶的表达和组织学肿瘤消退。
机译:直肠癌穿孔:直肠癌新辅助放疗的罕见并发症
机译:给予上直肠癌新辅助化学疗法后的外科结果
机译:Neoadjuvant在直肠癌中治疗:我们总是需要放射治疗 - 或者我们是否可以更好地评估当地先进的直肠癌?
机译:直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
机译:miR-302amiR-105和miR-888的表达在直肠癌患者的发病机制放疗和预后起到关键作用:直肠癌患者在瑞典直肠癌试验中的研究术前放疗到大数据库分析
机译:EP-1286:剂量递增的新辅助放疗是否可以改善直肠癌的病理反应?